Quick Answer
Autolus Therapeutics plc reported Net Income of -$287.53 million for fiscal year 2025.
Autolus Therapeutics plc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$287.53M | -30.3% |
| 2024 | -$220.66M | -5.9% |
| 2023 | -$208.38M | -40.0% |
| 2022 | -$148.84M | -4.7% |
| 2021 | -$142.10M | -0.0% |
| 2020 | -$142.09M | -14.7% |
| 2019 | -$123.85M | -176.8% |
| 2018 | -$44.75M | -126.9% |
| 2017 | -$19.73M | -57.2% |
| 2016 | -$12.55M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$79.12M | +3.6% | -65.1% |
| June 30, 2025 | -$47.92M | +17.8% | +31.7% |
| March 31, 2025 | -$70.16M | -33.2% | +14.5% |
| September 30, 2024 | -$82.09M | -79.1% | -40.9% |
| June 30, 2024 | -$58.27M | -27.9% | -10.6% |
| March 31, 2024 | -$52.69M | -32.4% | -14.9% |
| September 30, 2023 | -$45.85M | -7.2% | -0.7% |
| June 30, 2023 | -$45.55M | — | -14.4% |
- Autolus Therapeutics plc showed a decrease of -30.3% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, Autolus Therapeutics plc’s net income has declined by 2191.1% (from -$12.55 million to -$287.53 million).
- The most recent figure is from Autolus Therapeutics plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: